Home › Targets › melanocortin receptor

melanocortin receptor (2 companies · 3 programs)

Companies with an active program directed at melanocortin receptor.

Crinetics Pharmaceuticals, Inc. CRNX

atumelnant — Congenital Adrenal Hyperplasia Phase 3
atumelnant — Adrenal Crisis Phase 2

PALATIN TECHNOLOGIES INC PTN

bremelanotide — Obesity Phase 2